Antibody-Mediated Extreme Insulin Resistance: The Importance of Pre-Treatment Screening

Figure 1

Clinical course defined by daily insulin requirements and initiation of oral antihyperglycemic therapy, diagnosis of latent tuberculosis, and initiation of immunomodulatory therapy. Cycle 1 of immunomodulatory therapy was initiated concomitantly with latent tuberculosis treatment.